Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Clarus Therapeutics (CRXTW) Short Interest Ratio & Short Volume

Clarus Therapeutics logo

Clarus Therapeutics Short Interest Data

Clarus Therapeutics (CRXTW) has a short interest of 13,500 shares. This marks a -43.51% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 134,799 shares to cover all short positions.

Current Short Interest
13,500 shares
Previous Short Interest
23,900 shares
Change Vs. Previous Month
-43.51%
Dollar Volume Sold Short
$803.25
Short Interest Ratio
0.3 Days to Cover
Last Record Date
August 15, 2022
Today's Trading Volume
0 shares
Average Trading Volume
134,799 shares
Today's Volume Vs. Average
0%
Short Selling Clarus Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Clarus Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CRXTW Short Interest Over Time

CRXTW Days to Cover Over Time

CRXTW Percentage of Float Shorted Over Time

Clarus Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/15/202213,500 shares $803.25 -43.5%N/A0.3 $0.06
7/31/202223,900 shares $1,491.36 +431.1%N/A0.5 $0.06
7/15/20224,500 shares $314.10 -83.9%N/A0 $0.07
6/30/202228,000 shares $2,240.00 +3.7%N/A0.1 $0.08
6/15/202227,000 shares $1,890.00 -60.0%N/A0.1 $0.07
5/31/202267,500 shares $5,076.00 -24.6%N/A0.2 $0.08
5/15/202289,500 shares $7,553.80 +1,981.4%N/A0.3 $0.08
4/30/20224,300 shares $455.37 -73.0%N/A0 $0.11
4/15/202215,900 shares $2,226.00 -29.0%N/A0.1 $0.14
3/31/202222,400 shares $0.00 +446.3%N/A0.3 $0.00

CRXTW Short Interest - Frequently Asked Questions

What is Clarus Therapeutics' current short interest?

Short interest is the volume of Clarus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 15th, traders have sold 13,500 shares of CRXTW short. Learn More on Clarus Therapeutics' current short interest.

Is Clarus Therapeutics' short interest increasing or decreasing?

Clarus Therapeutics saw a decrease in short interest in August. As of August 15th, there was short interest totaling 13,500 shares, a decrease of 43.5% from the previous total of 23,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($4.13 billion), Charter Communications, Inc. ($3.94 billion), Coinbase Global, Inc. ($2.38 billion), Lucid Group, Inc. ($2.30 billion), T. Rowe Price Group, Inc. ($2.22 billion), Williams-Sonoma, Inc. ($2.02 billion), Plug Power Inc. ($1.94 billion), Chesapeake Energy Co. ($1.91 billion), Unity Software Inc. ($1.82 billion), and Rivian Automotive, Inc. ($1.74 billion). View all of the most shorted stocks.

What does it mean to sell short Clarus Therapeutics stock?

Short selling CRXTW is an investing strategy that aims to generate trading profit from Clarus Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Clarus Therapeutics?

A short squeeze for Clarus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRXTW, which in turn drives the price of the stock up even further.

How often is Clarus Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRXTW, twice per month. The most recent reporting period available is August, 15 2022.




This page (NASDAQ:CRXTW) was last updated on 4/23/2025 by MarketBeat.com Staff
From Our Partners